Signant Health vs YPrime

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/signanthealth/yprime

Category	Signant Health	YPrime
Listed site	cro	cro
Summary	Clinical trial technology and services provider with 30 years of experience supporting thousands of trials and 25% of novel drug approvals (FDA/EMA, 2021–2024). Offers eClinical solutions, protocol guidance from 50+ in-house scientists and clinicians, and global operational scale.	YPrime delivers configurable eCOA, IRT, and eConsent clinical trial technology platforms with consulting services, supporting ~1,000 studies globally across 19+ therapeutic areas.
Services	Clinical Operations Data Management & eClinical Biostatistics & Statistical Programming Medical Writing US FDA Regulatory Strategy EU EMA Regulatory Strategy Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Trial Services	Data Management & eClinical Biostatistics & Statistical Programming Clinical Operations Clinical Trial Services Medical Writing Regulatory Affairs Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing
Modalities	Vaccine	Data not yet provided.
Indications	Oncology Neurology Psychiatry	Oncology Immunology Neurology Metabolic Infectious Disease Rare Disease Ophthalmology
Locations	Headquarters, Blue Bell, Pennsylvania, United States Horsham, Horsham, Pennsylvania, United States Helsinki, Helsinki, Uusimaa, Finland Iași, Iași, Iași, Romania Milton Keynes, Milton Keynes, Buckinghamshire, United Kingdom Dublin, Dublin, Dublin, Ireland Hyderabad, Hyderabad, Telangana, India Noida, Noida, Uttar Pradesh, India	Data not yet provided.
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.